Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 5329

1.

Autoimmune polyendocrine syndrome and thrombocytosis.

Atquet V, Lienart F, Vaes M.

Acta Clin Belg. 2015 Jul 31:2295333715Y0000000056. [Epub ahead of print]

PMID:
26229032
2.

Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review.

Ogaki K, Koga S, Aoki N, Lin W, Suzuki K, Ross OA, Dickson DW.

Neuropathology. 2015 Jul 31. doi: 10.1111/neup.12230. [Epub ahead of print]

PMID:
26227820
3.

The Role of Fludrocortisone in Cognition and Mood in Patients with Primary Adrenal Insufficiency (Addison's Disease).

Schultebraucks K, Wingenfeld K, Otte C, Quinkler M.

Neuroendocrinology. 2015 Jul 24. [Epub ahead of print]

PMID:
26227663
4.

Expression of melanocortin receptors in human endometrium.

Lantang AM, Innes BA, Gan EH, Pearce SH, Lash GE.

Hum Reprod. 2015 Jul 29. pii: dev188. [Epub ahead of print]

5.

Clinical Perspective: What Do Addison and Cushing Tell Us About Glucocorticoid Action?

Harris C.

Adv Exp Med Biol. 2015;872:83-96. doi: 10.1007/978-1-4939-2895-8_4.

PMID:
26215991
6.

Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.

Al-Baimani K, Bazzarelli A, Clemons M, Robertson SJ, Addison C, Arnaout A.

Clin Breast Cancer. 2015 Jun 22. pii: S1526-8209(15)00144-5. doi: 10.1016/j.clbc.2015.06.010. [Epub ahead of print] Review.

PMID:
26209026
7.

Incidence of Adrenal Crisis in patients with Adrenal Insufficiency.

Smans LC, Van der Valk ES, Hermus AR, Zelissen PM.

Clin Endocrinol (Oxf). 2015 Jul 24. doi: 10.1111/cen.12865. [Epub ahead of print]

PMID:
26208266
8.

CTLA-4 as a genetic determinant in autoimmune Addison's disease.

Wolff AS, Mitchell AL, Cordell HJ, Short A, Skinningsrud B, Ollier W, Badenhoop K, Meyer G, Falorni A, Kampe O, Undlien D, Pearce SH, Husebye ES.

Genes Immun. 2015 Jul 23. doi: 10.1038/gene.2015.27. [Epub ahead of print]

PMID:
26204230
9.

Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence.

Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, Gupta B, Grant R, Addison PK, Westcott M, Pavesio CE.

Br J Ophthalmol. 2015 Jul 17. pii: bjophthalmol-2014-306474. doi: 10.1136/bjophthalmol-2014-306474. [Epub ahead of print]

PMID:
26187952
10.

Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.

Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, Karamouzis I, Lucchiari M, Manetta T, Mengozzi G, Arvat E, Ghigo E.

Endocrine. 2015 Jul 17. [Epub ahead of print]

PMID:
26184416
11.

Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Lubick KJ, Robertson SJ, McNally KL, Freedman BA, Rasmussen AL, Taylor RT, Walts AD, Tsuruda S, Sakai M, Ishizuka M, Boer EF, Foster EC, Chiramel AI, Addison CB, Green R, Kastner DL, Katze MG, Holland SM, Forlino A, Freeman AF, Boehm M, Yoshii K, Best SM.

Cell Host Microbe. 2015 Jul 8;18(1):61-74. doi: 10.1016/j.chom.2015.06.007.

PMID:
26159719
12.

Generalized vitiligo in a dog with primary hypoadrenocorticism.

Malerba E, Morini M, Fracassi F.

Vet Dermatol. 2015 Jun 23. doi: 10.1111/vde.12228. [Epub ahead of print]

PMID:
26104920
13.

Risk of Cancer of Unknown Primary after Hospitalization for Autoimmune Diseases.

Hemminki K, Sundquist K, Sundquist J, Ji J.

Int J Cancer. 2015 Jun 23. doi: 10.1002/ijc.29657. [Epub ahead of print]

PMID:
26103152
14.

Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients.

Punga AR, Andersson M, Alimohammadi M, Punga T.

J Neurol Sci. 2015 Jun 14. pii: S0022-510X(15)00360-3. doi: 10.1016/j.jns.2015.06.019. [Epub ahead of print]

15.

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.

Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W.

Oncotarget. 2015 Jun 7. [Epub ahead of print]

16.

Achalasia in a Patient with Polyglandular Autoimmune Syndrome Type II.

Amr BS, Mamillapalli C.

Case Rep Gastroenterol. 2015 May 13;9(2):160-4. doi: 10.1159/000430493. eCollection 2015 May-Aug.

17.

Alcoholic Cirrhosis Increases Risk for Autoimmune Diseases: A Nationwide Registry-Based Cohort Study.

Grønbæk L, Vilstrup H, Deleuran B, Wiest R, Krag A, Jepsen P.

Clin Gastroenterol Hepatol. 2015 Jun 1. pii: S1542-3565(15)00767-3. doi: 10.1016/j.cgh.2015.05.032. [Epub ahead of print]

PMID:
26044312
18.

Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.

Mitchell AL, Bøe Wolff A, MacArthur K, Weaver JU, Vaidya B; Sophie Bensing on behalf of The Swedish Addison Registry Study Group, Erichsen MM, Darlay R, Husebye ES, Cordell HJ, Pearce SH.

PLoS One. 2015 Jun 4;10(6):e0123550. doi: 10.1371/journal.pone.0123550. eCollection 2015.

19.

A Case of Autoimmune Polyglandular Syndrome (APS) Type II with Hypothyroidism, Hypoadrenalism, and Celiac Disease - A Rare Combination.

Lakhotia M, Pahadia HR, Kumar H, Singh J, Tak S.

J Clin Diagn Res. 2015 Apr;9(4):OD01-3. doi: 10.7860/JCDR/2015/10755.5748. Epub 2015 Apr 1.

20.

Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease.

Thompson MD, Kalmar E, Bowden SA.

BMJ Case Rep. 2015 May 28;2015. pii: bcr2015209903. doi: 10.1136/bcr-2015-209903.

PMID:
26021383
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk